Advanced search
Publication Cover
Expert Review of Hematology Volume 6, 2013 - Issue 2
Submit an article Journal homepage
49
Views
1
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Prophylactic use of granulocyte colony-stimulating factor after consolidation therapy with high-dose cytarabine for acute myeloid leukemia

Mazyar Shadman Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA 98109, USA. [email protected]
&
Elihu H Estey Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA 98109, USA
Pages 131-133 | Published online: 10 Jan 2014

References

  • Pabst T, Vellenga E, van Putten W et al.; Dutch–Belgian Hemato-Oncology Cooperative Group (HOVON); German AML Study Group (AMLSG); Swiss Collaborative Group for Clinical Cancer Research (SAKK). Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine. Blood 119(23), 5367–5373 (2012).
  • Wadleigh M, Stone RM. The role of myeloid growth factors in acute leukemia. J. Natl Compr. Canc. Netw. 7(1), 84–91 (2009).
  • Gurion R, Belnik-Plitman Y, Gafter-Gvili A et al. Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia. Cochrane Database Syst. Rev. 6, CD008238 (2012).
  • Smith TJ, Khatcheressian J, Lyman GH et al. 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J. Clin. Oncol. 24(19), 3187–3205 (2006).
  • O’Donnell MR, Abboud CN, Altman J et al. Acute myeloid leukemia. J. Natl Compr. Canc. Netw. 10(8), 984–1021 (2012).
  • Bradley AM, Deal AM, Buie LW, van Deventer H. Neutropenia-associated outcomes in adults with acute myeloid leukemia receiving cytarabine consolidation chemotherapy with or without granulocyte colony-stimulating factor. Pharmacotherapy 32(12), 1070–1077 (2012).
  • Harousseau JL, Witz B, Lioure B et al. Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: results of a randomized trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques. J. Clin. Oncol. 18(4), 780–787 (2000).
  • Heil G, Hoelzer D, Sanz MA et al.; The International Acute Myeloid Leukemia Study Group. A randomized, double-blind, placebo-controlled, Phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. Blood 90(12), 4710–4718 (1997).
  • Döhner H, Estey EH, Amadori S et al.; European LeukemiaNet. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115(3), 453–474 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.